28
Our mission is to assist MS sufferers in obtaining treatments not available in the standard medical system.

What We D o

  • Upload
    gretel

  • View
    20

  • Download
    0

Embed Size (px)

DESCRIPTION

Our mission is to assist MS sufferers in obtaining treatments not available in the standard medical system. What We D o. - PowerPoint PPT Presentation

Citation preview

Page 1: What We  D o

Our mission is to assist MS sufferers in obtaining treatments not available in

the standard medical system.

Page 2: What We  D o

What We Do

The WAMS Foundation focuses on helping MS sufferers’ access alternative treatments that aren’t available to them through the standard medical system or are beyond

their financial means. WAMS aims to enhance the quality of life of MS patients.

Page 3: What We  D o

How We Do It

WAMS makes a difference one patient at a time. Donations will be used to help a specific person

get the treatment they seek.

Page 4: What We  D o

Who Started the Walk A Myelin Our Shoes Foundation (WAMS)?

The WAMS Foundation was founded by Carmen Amundsen, her cousin Melanie Pump and her

partner Jennie deFoy. Carmen is an MS sufferer who wished to help other MS sufferers attain alternative therapies they could not afford.

Page 5: What We  D o

Why is the Foundation called Walk A Myelin Our Shoes (WAMS)?

Myelin refers to the Myelin sheath, the covering on the nerves, MS damages the Myelin and

exposes the nerves which causes demyelination.

Page 6: What We  D o

How is the WAMS Foundation Different from others MS Societies and Organizations?

The core purpose of the WAMS Foundation is to help MS sufferers improve their quality of life.

The WAMS foundation is not politically aligned; our goal is to educate the public and help MS

sufferers access alternative therapies to alleviate their symptoms.

Page 7: What We  D o

How is the WAMS Foundation funded?

To do our work we rely heavily on public and corporate donations, to donate toour foundation please visit us at

www.wamsfoundation.com

Page 8: What We  D o

WAMS puts a face on the disease, so the world understands the suffering and the need for quick

action and research to find a cure for the harrowing disease.

Page 9: What We  D o

What is Multiple Sclerosis?

Multiple Sclerosis is an unpredictable, often disabling disease of the central nervous system.

The disease attacks the myelin which is a protective covering wrapped around the nerves,

causing crippling effects to its sufferers.

Page 10: What We  D o

What is CCSVI?

CCSVI stands for chronic cerebrospinal venous insufficiency. The term is used

to describe compromised flow of blood in the veins that drain the central nervous system.

Page 11: What We  D o

What alternative therapies are available for MS sufferers?

Acupuncture, Naturopathy, CCSVI, stem cell therapies and many other treatments have had

promising results for MS patients.

Page 12: What We  D o

Canadians have one of the highest rates of Multiple Sclerosis in the

world

Page 13: What We  D o

Multiple Sclerosis is the most common neurological disease in Canada

Page 14: What We  D o

Every day, three more people in Canada are diagnosed with Multiple Sclerosis

Page 15: What We  D o

Women are three times more likely to develop Multiple Sclerosis

Page 16: What We  D o

Multiple Sclerosis can cause loss of balance, impaired speech, extreme fatigue,

double vision and paralysis

Page 17: What We  D o

Canada is a high risk area for Multiple Sclerosis, which occurs more often in

countries, like Canada that are further away from the equator

Page 18: What We  D o

The cause of MS is not known

Page 19: What We  D o

MS is not contagious, and is not inherited

Page 20: What We  D o

Multiple sclerosis can occur at any age

Page 21: What We  D o

An estimated 55,000-75,000 Canadians have Multiple Sclerosis. Prevalence rates inCanada are one of the highest in the world.

Page 22: What We  D o

There are four types of Multiple Sclerosis:

Relapsing Remitting MS (RRMS)Primary Progressive MS (PPMS)

Secondary Progressive MS (SPMS) Progressive Relapsing MS (PRMS)

Page 23: What We  D o

Relapsing Remitting MS

RRMS is a type of MS characterized by unpredictable but clearly defined episodes

during which new symptoms appear, or existing ones get worse. About 85% of people have

RRMS at the time of diagnosis.

Page 24: What We  D o

Primary Progressive MS

PPMS characterized by a slow accumulationof disability, without relapses. It may stabilize for

periods of time, and even offer minortemporary improvement, but overall, there are

not periods of remission in PPMS.Approximately 10% of people diagnosed with

MS have PPMS.

Page 25: What We  D o

Secondary Progressive MS

SPMS follows on a course of RRMS. Over time, distinct relapses and remissions become less apparent and the disease begins to worsen

steadily. About 50% of people with RRMS will develop SPMS within 10 years of diagnosis.

Page 26: What We  D o

Progressive Relapsing MS

PRMS is the rarest type of MS, occurring in only about 5% of people diagnosed. People with this

form of MS experience steadily worsening disease from the beginning, but also experience

clear attacks of symptoms, with or without recovery.

Page 27: What We  D o

There is no cure for Multiple Sclerosis

Page 28: What We  D o

How do I apply to receive funding from the WAMS Foundation?

To receive financial aid from the WAMS Foundation please apply atwww.wamsfoundation.com